bupivacaine has been researched along with Neoplasms in 52 studies
Bupivacaine: A widely used local anesthetic agent.
1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide : A piperidinecarboxamide obtained by formal condensation of the carboxy group of N-butylpipecolic acid with the amino group of 2,6-dimethylaniline.
bupivacaine : A racemate composed of equimolar amounts of dextrobupivacaine and levobupivacaine. Used (in the form of its hydrochloride hydrate) as a local anaesthetic.
Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
Excerpt | Relevance | Reference |
---|---|---|
" We included 14 patients aged 18 years and above, implanted with an Intrathecal Drug Delivery Systems (IDDS) for cancer pain treatment and followed up at ICO from July 2020 to February 2021 after switching from ropivacaine to bupivacaine." | 8.02 | First Evaluation Switching From Ropivacaine to Highly Concentrated Bupivacaine in Intrathecal Mixtures for Cancer Pain. ( Bellanger, M; Bienfait, F; Boré, F; Delorme, T; Dupoiron, D; Jaoul, V; Jubier-Hamon, S; Lebrec, N; Pluchon, YM; Robert, J; Seegers, V; Sorrieul, J, 2021) |
"Fifteen patients with pain due to advanced cancer who no longer obtained relief from conventional treatment using oral or parenteral opioids were administered morphine and bupivacaine by continuous intrathecal infusion." | 7.69 | Intrathecal morphine and bupivacaine in advanced cancer pain patients implanted at home. ( Mercadante, S, 1994) |
"In 53 patients, the clinical efficacy was estimated from: pain relief (visual analog scale scores 0-10); daily dosages (intrathecal and total opioid and intrathecal bupivacaine); scores (0-5) of nonopioid analgesic and sedative consumption, gait and daily activity, and amount of sleep; and rates of adverse effects." | 7.69 | Long-term intrathecal morphine and bupivacaine in patients with refractory cancer pain. Results from a morphine:bupivacaine dose regimen of 0.5:4.75 mg/ml. ( Appelgren, L; Curelaru, I; Nitescu, P; Sjöberg, M, 1994) |
"Epidural or intrathecal infusions of morphine and bupivacaine mixtures are presently used for the treatment of "refractory" cancer pain even though the neurotoxic potential of such mixtures is unknown." | 7.68 | Neuropathologic findings after long-term intrathecal infusion of morphine and bupivacaine for pain treatment in cancer patients. ( Appelgren, L; Curelaru, I; Karlsson, PA; Linder, LE; Nitescu, P; Nordborg, C; Sjöberg, M; Wallgren, A, 1992) |
" We included 14 patients aged 18 years and above, implanted with an Intrathecal Drug Delivery Systems (IDDS) for cancer pain treatment and followed up at ICO from July 2020 to February 2021 after switching from ropivacaine to bupivacaine." | 4.02 | First Evaluation Switching From Ropivacaine to Highly Concentrated Bupivacaine in Intrathecal Mixtures for Cancer Pain. ( Bellanger, M; Bienfait, F; Boré, F; Delorme, T; Dupoiron, D; Jaoul, V; Jubier-Hamon, S; Lebrec, N; Pluchon, YM; Robert, J; Seegers, V; Sorrieul, J, 2021) |
"Fifteen patients with pain due to advanced cancer who no longer obtained relief from conventional treatment using oral or parenteral opioids were administered morphine and bupivacaine by continuous intrathecal infusion." | 3.69 | Intrathecal morphine and bupivacaine in advanced cancer pain patients implanted at home. ( Mercadante, S, 1994) |
"In 53 patients, the clinical efficacy was estimated from: pain relief (visual analog scale scores 0-10); daily dosages (intrathecal and total opioid and intrathecal bupivacaine); scores (0-5) of nonopioid analgesic and sedative consumption, gait and daily activity, and amount of sleep; and rates of adverse effects." | 3.69 | Long-term intrathecal morphine and bupivacaine in patients with refractory cancer pain. Results from a morphine:bupivacaine dose regimen of 0.5:4.75 mg/ml. ( Appelgren, L; Curelaru, I; Nitescu, P; Sjöberg, M, 1994) |
"Five children with cancer pain were given continuous intrathecal morphine or fentanyl infusion associated with bupivacaine 0." | 3.68 | [Intrathecal morphine therapy in children with cancer]. ( Ganansia, MF; Lejus, C; Meignier, M; Testa, S, 1992) |
"Epidural or intrathecal infusions of morphine and bupivacaine mixtures are presently used for the treatment of "refractory" cancer pain even though the neurotoxic potential of such mixtures is unknown." | 3.68 | Neuropathologic findings after long-term intrathecal infusion of morphine and bupivacaine for pain treatment in cancer patients. ( Appelgren, L; Curelaru, I; Karlsson, PA; Linder, LE; Nitescu, P; Nordborg, C; Sjöberg, M; Wallgren, A, 1992) |
"The role of epidural morphine in chronic cancer pain treatment is unresolved." | 3.68 | Epidural opiates and local anesthetics for the management of cancer pain. ( Abram, S; Haddox, DJ; Hogan, Q; Janjan, N; Taylor, ML; Weissman, D, 1991) |
"Twenty patients with cancer were selected for intrathecal treatment because of either side effects or inadequate relief during conventional pain treatment." | 2.69 | Intrathecal coadministration of bupivacaine diminishes morphine dose progression during long-term intrathecal infusion in cancer patients. ( Crul, BJ; van Dongen, RT; van Egmond, J, 1999) |
"Twenty-seven adults with cancer pain were prospectively selected according to their primary lesions and problems, but their allocation to study groups was randomized." | 2.67 | Prolongation of epidural bupivacaine analgesia with glycerin. ( King, H; Wooten, DJ; Xiao, CS, 1993) |
"Up to 90% of patients with advanced cancer experience intractable pain." | 2.50 | Treatment of medically refractory cancer pain with a combination of intrathecal neuromodulation and neurosurgical ablation: case series and literature review. ( Bentley, JN; Patil, PG; Rosenberg, WS; Viswanathan, A, 2014) |
" Chronic use of pain medications and older age were predictors of inadequate pain control postoperatively." | 1.48 | Factors Associated with Inadequate Pain Control among Postoperative Patients with Cancer. ( Al-Najar, M; Darawad, M; El-Aqoul, A; Obaid, A; Ramadan, M; Yacoub, E, 2018) |
"A multidisciplinary interventional cancer pain service was established in the West of Scotland in 2008 with the aim of providing a safe and effective intrathecal drug delivery service for patients with difficult-to-control cancer pain." | 1.42 | Audit of intrathecal drug delivery for patients with difficult-to-control cancer pain shows a sustained reduction in pain severity scores over a 6-month period. ( McGhie, J; McGinn, G; Mitchell, A; Owen, M, 2015) |
"Pain in terminal cancer patients may be refractory to systemic analgesics or associated with adverse drug reactions to analgesics." | 1.38 | Efficacy of epidural analgesia in patients with cancer pain: a retrospective observational study. ( Choi, JW; Jeon, YS; Joo, JD; Jung, HS; Kang, EG; Kim, HK; Lee, JA; Park, JH; Shim, BY, 2012) |
"We present two cases of cancer patients with intractable mechanical and visceral pain that was unrelieved with either comprehensive medical management or intrathecal morphine who received intrathecal bupivacaine." | 1.32 | Efficacy of intrathecal bupivacaine: how important is the flow rate? ( Buchser, E; Chédel, D; Durrer, A; Mustaki, JP, 2004) |
" Five patients showed symptoms of compression of the cauda equina or spinal cord shortly after the start of combined IT administration of morphine and bupivacaine in a dosage usually not associated with neurologic symptoms." | 1.30 | Neurological impairment during long-term intrathecal infusion of bupivacaine in cancer patients: a sign of spinal cord compression. ( Crul, BJ; van Dongen, RT; van Ee, R, 1997) |
"As the number of terminal cancer patients receiving continuous intrathecal infusion of opioids and local anesthetics for relief of pain increases, we decided to investigate the post-mortem findings of the spinal cord, meninges and nerve roots of patients after continuous intrathecal administration of morphine and combined with bupivacaine." | 1.30 | Neurohistopathological findings after continuous intrathecal administration of morphine or a morphine/bupivacaine mixture in cancer pain patients. ( de Lange, JJ; Spoelder, EM; van der Valk, P; Wagemans, MF; Zuurmond, WW, 1997) |
"We prospectively studied surgical cancer patients who received epidural bupivacaine-morphine to determine perioperative morphine use, side effects, and complications." | 1.29 | Postoperative epidural bupivacaine-morphine therapy. Experience with 4,227 surgical cancer patients. ( de Leon-Casasola, OA; Harrison, P; Lema, MJ; Massey, J; Parker, B, 1994) |
" Bupivacaine-induced side effects were absent below a daily dosage of 30 mg by continuous infusion." | 1.29 | Long-term intrathecal infusion of morphine and morphine/bupivacaine mixtures in the treatment of cancer pain: a retrospective analysis of 51 cases. ( Crul, BJP; De Bock, M; Van Dongen, RTM, 1993) |
"This study evaluated 20 chronic cancer pain patients who underwent abdominal surgery for tumor resection." | 1.29 | Epidural bupivacaine/sufentanil therapy for postoperative pain control in patients tolerant to opioid and unresponsive to epidural bupivacaine/morphine. ( de Leon-Casasola, OA; Lema, MJ, 1994) |
" Thus, epidural BUP-MS appears to provide adequate postoperative analgesia while preventing withdrawal in opioid-dependent patients, if three times the normal dosage and duration of therapy are employed." | 1.29 | A comparison of postoperative epidural analgesia between patients with chronic cancer taking high doses of oral opioids versus opioid-naive patients. ( Bacon, DR; de Leon-Casasola, OA; Donaparthi, S; Lema, MJ; Myers, DP; Peppriell, J; Rempel, J, 1993) |
"The treatment of severe cancer pain by intrathecal infusion of morphine and bupivacaine seems to be a promising method." | 1.29 | [Treatment of severe cancer pain via spinal catheters]. ( Andersen, JS; Markers, PI; Valentin, N, 1996) |
" We conclude that epidural opioid-bupivacaine infusion is an effective and safe technique for long-term administration of analgesics in the refractory cancer patient." | 1.28 | Chronic epidural bupivacaine-opioid infusion in intractable cancer pain. ( Du Pen, SL; Hasche-Klunder, H; Kharasch, ED; Krembs, AW; Peterson, DG; Sloan, DC; Williams, A, 1992) |
"Fifteen adult patients with cancer pain received 0." | 1.28 | [Epidural administration of bupivacaine in glycerine solution can prolong analgesia]. ( King, HK; Wooten, DJ; Xiao, CS, 1992) |
" The efficacy of the treatment was estimated from: 1) daily dosage (intraspinal and total opiates, and intraspinal bupivacaine), and 2) scores of non-opiate analgesic and sedative consumption, gait and daily activities, and amount and pattern of sleep." | 1.28 | Long-term intrathecal morphine and bupivacaine in "refractory" cancer pain. I. Results from the first series of 52 patients. ( Appelgren, L; Curelaru, I; Einarsson, S; Hultman, E; Linder, LE; Nitescu, P; Sjöberg, M, 1991) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (13.46) | 18.7374 |
1990's | 27 (51.92) | 18.2507 |
2000's | 6 (11.54) | 29.6817 |
2010's | 7 (13.46) | 24.3611 |
2020's | 5 (9.62) | 2.80 |
Authors | Studies |
---|---|
Abdelemam, RM | 2 |
Fares, KM | 2 |
Kamal, SM | 1 |
Abdelghaffar, NA | 1 |
Farahat, TE | 1 |
Maharani, ND | 1 |
Fuadi, A | 1 |
Halimi, RA | 1 |
Mohamed, SA | 1 |
Abd El-Rahman, AM | 1 |
Osman, AMM | 1 |
Bienfait, F | 1 |
Jubier-Hamon, S | 1 |
Seegers, V | 1 |
Pluchon, YM | 1 |
Lebrec, N | 1 |
Jaoul, V | 1 |
Boré, F | 1 |
Delorme, T | 1 |
Robert, J | 1 |
Bellanger, M | 1 |
Sorrieul, J | 1 |
Dupoiron, D | 1 |
El-Aqoul, A | 1 |
Obaid, A | 1 |
Yacoub, E | 1 |
Al-Najar, M | 1 |
Ramadan, M | 1 |
Darawad, M | 1 |
De Andres, J | 1 |
Asensio-Samper, JM | 1 |
Fabregat-Cid, G | 1 |
Bentley, JN | 1 |
Viswanathan, A | 1 |
Rosenberg, WS | 1 |
Patil, PG | 1 |
Mitchell, A | 1 |
McGhie, J | 1 |
Owen, M | 1 |
McGinn, G | 1 |
Purdy, M | 1 |
Kärkkäinen, J | 1 |
Kokki, M | 1 |
Anttila, M | 1 |
Aspinen, S | 1 |
Juvonen, P | 1 |
Kokki, H | 1 |
Pulkki, K | 1 |
Rantanen, T | 1 |
Eskelinen, M | 1 |
Sato, C | 1 |
Okabe, T | 1 |
Nakanishi, K | 1 |
Sakamoto, A | 1 |
Jeon, YS | 1 |
Lee, JA | 1 |
Choi, JW | 1 |
Kang, EG | 1 |
Jung, HS | 1 |
Kim, HK | 1 |
Shim, BY | 1 |
Park, JH | 1 |
Joo, JD | 1 |
Breitfeld, C | 1 |
Eikermann, M | 1 |
Kienbaum, P | 1 |
Peters, J | 1 |
Mercadante, S | 4 |
Villari, P | 3 |
Ferrera, P | 3 |
Arcuri, E | 3 |
Buchser, E | 1 |
Durrer, A | 1 |
Chédel, D | 1 |
Mustaki, JP | 1 |
Baker, L | 1 |
Lee, M | 1 |
Regnard, C | 1 |
Crack, L | 1 |
Callin, S | 1 |
Mangione, S | 1 |
Mocavero, G | 1 |
Rinaldi, A | 1 |
Lotti, GG | 1 |
Bevilacqua, P | 1 |
Nitescu, P | 6 |
Sjöberg, M | 6 |
Appelgren, L | 6 |
Curelaru, I | 6 |
de Leon-Casasola, OA | 3 |
Parker, B | 1 |
Lema, MJ | 3 |
Harrison, P | 1 |
Massey, J | 1 |
Van Dongen, RTM | 1 |
Crul, BJP | 1 |
De Bock, M | 1 |
Samuelsson, H | 1 |
Ekman, R | 1 |
Hedner, T | 1 |
Myers, DP | 1 |
Donaparthi, S | 1 |
Bacon, DR | 1 |
Peppriell, J | 1 |
Rempel, J | 1 |
Jayr, C | 1 |
Thomas, H | 1 |
Rey, A | 1 |
Farhat, F | 1 |
Lasser, P | 1 |
Bourgain, JL | 1 |
King, H | 1 |
Xiao, CS | 2 |
Wooten, DJ | 2 |
Ricci, V | 1 |
Dalpane, A | 1 |
Lolli, E | 1 |
Andersen, JS | 1 |
Markers, PI | 1 |
Valentin, N | 1 |
van Dongen, RT | 2 |
van Ee, R | 1 |
Crul, BJ | 2 |
Wagemans, MF | 1 |
van der Valk, P | 1 |
Spoelder, EM | 1 |
Zuurmond, WW | 1 |
de Lange, JJ | 1 |
Antila, H | 1 |
Kirvelä, O | 1 |
Amesbury, B | 1 |
O'Riordan, J | 1 |
Dolin, S | 1 |
van Egmond, J | 1 |
Du Pen, SL | 2 |
Kharasch, ED | 1 |
Williams, A | 1 |
Peterson, DG | 1 |
Sloan, DC | 1 |
Hasche-Klunder, H | 1 |
Krembs, AW | 1 |
Meignier, M | 1 |
Ganansia, MF | 1 |
Lejus, C | 1 |
Testa, S | 1 |
de Jong, PC | 1 |
Kansen, PJ | 1 |
Williams, AR | 1 |
King, HK | 1 |
Karlsson, PA | 1 |
Nordborg, C | 1 |
Wallgren, A | 1 |
Linder, LE | 4 |
Hogan, Q | 1 |
Haddox, DJ | 1 |
Abram, S | 1 |
Weissman, D | 1 |
Taylor, ML | 1 |
Janjan, N | 1 |
Hultman, E | 3 |
Einarsson, S | 1 |
Hunt, R | 1 |
Massolino, J | 1 |
Sjøgren, P | 1 |
Gefke, K | 1 |
Banning, AM | 1 |
Parslov, M | 1 |
Overgaard Olsen, LB | 1 |
Moulin, DE | 1 |
Coyle, N | 1 |
Müller, H | 1 |
Biscoping, J | 1 |
Gips, H | 1 |
Tilkes, F | 1 |
Strunz, P | 1 |
Hempelmann, G | 1 |
Hannington-Kiff, JG | 1 |
Swerdlow, M | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Oxidative Stress and Inflammation Biomarkers in Correlation to Postoperative Pain Modulation in Surgically Treated Patients With Laryngeal Cancer[NCT05857202] | 100 participants (Anticipated) | Observational | 2022-09-01 | Recruiting | |||
Conscious Dying/Conscious Living: Ketamine-Assisted Psychotherapy (KAP) for Patients at End of Life-A Pilot Study for Palliative and Hospice Care[NCT05214417] | Phase 2 | 120 participants (Anticipated) | Interventional | 2022-05-01 | Not yet recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
3 reviews available for bupivacaine and Neoplasms
Article | Year |
---|---|
Intrathecal delivery of analgesics.
Topics: Analgesics, Opioid; Baclofen; Bupivacaine; Catheters, Indwelling; Chronic Pain; Clonidine; Drug Deli | 2014 |
Intrathecal delivery of analgesics.
Topics: Analgesics, Opioid; Baclofen; Bupivacaine; Catheters, Indwelling; Chronic Pain; Clonidine; Drug Deli | 2014 |
Treatment of medically refractory cancer pain with a combination of intrathecal neuromodulation and neurosurgical ablation: case series and literature review.
Topics: Adolescent; Aged; Bone Neoplasms; Bupivacaine; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell | 2014 |
Treatment of medically refractory cancer pain with a combination of intrathecal neuromodulation and neurosurgical ablation: case series and literature review.
Topics: Adolescent; Aged; Bone Neoplasms; Bupivacaine; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell | 2014 |
[Continuous spinal analgesia in home care of oncologic pain].
Topics: Analgesics, Opioid; Bupivacaine; Clonidine; Home Infusion Therapy; Humans; Infusion Pumps, Implantab | 1995 |
[Continuous spinal analgesia in home care of oncologic pain].
Topics: Analgesics, Opioid; Bupivacaine; Clonidine; Home Infusion Therapy; Humans; Infusion Pumps, Implantab | 1995 |
9 trials available for bupivacaine and Neoplasms
Article | Year |
---|---|
Effect of Combined Epidural Morphine and Midazolam on Postoperative Pain in Patients Undergoing Major Abdominal Cancer Surgery.
Topics: Analgesia, Epidural; Analgesics; Analgesics, Opioid; Anesthetics, Local; Bupivacaine; Double-Blind M | 2022 |
Effect of Combined Epidural Morphine and Midazolam on Postoperative Pain in Patients Undergoing Major Abdominal Cancer Surgery.
Topics: Analgesia, Epidural; Analgesics; Analgesics, Opioid; Anesthetics, Local; Bupivacaine; Double-Blind M | 2022 |
Fluoroscopic anterior approach versus ultrasound guided superior hypogastric plexus neurolysis in cancer pelvic pain: a randomized controlled study.
Topics: Bupivacaine; Cancer Pain; Fluoroscopy; Humans; Hypogastric Plexus; Neoplasms; Nerve Block; Pelvic Pa | 2022 |
Fluoroscopic anterior approach versus ultrasound guided superior hypogastric plexus neurolysis in cancer pelvic pain: a randomized controlled study.
Topics: Bupivacaine; Cancer Pain; Fluoroscopy; Humans; Hypogastric Plexus; Neoplasms; Nerve Block; Pelvic Pa | 2022 |
Comparison of the effect of scalp block analgesia bupivacaine 0.25% and clonidine 2 μg/kg with bupivacaine 0.25% and dexamethasone 8 mg on cortisol levels and Numeric Rating Scale in craniotomy tumour.
Topics: Analgesia; Anesthetics, Local; Bupivacaine; Clonidine; Craniotomy; Dexamethasone; Humans; Hydrocorti | 2023 |
Comparison of the effect of scalp block analgesia bupivacaine 0.25% and clonidine 2 μg/kg with bupivacaine 0.25% and dexamethasone 8 mg on cortisol levels and Numeric Rating Scale in craniotomy tumour.
Topics: Analgesia; Anesthetics, Local; Bupivacaine; Clonidine; Craniotomy; Dexamethasone; Humans; Hydrocorti | 2023 |
Analgesic Effect of Intrathecal Fentanyl vs Dexmedetomidine as Adjuvants to Bupivacaine Following Abdominal Surgery for Cancer in Children, a Randomized Trial.
Topics: Analgesics; Anesthetics, Local; Bupivacaine; Child; Dexmedetomidine; Double-Blind Method; Fentanyl; | 2020 |
Analgesic Effect of Intrathecal Fentanyl vs Dexmedetomidine as Adjuvants to Bupivacaine Following Abdominal Surgery for Cancer in Children, a Randomized Trial.
Topics: Analgesics; Anesthetics, Local; Bupivacaine; Child; Dexmedetomidine; Double-Blind Method; Fentanyl; | 2020 |
Does Rectus Sheath Block Analgesia Alter Levels of the Oxidative Stress Biomarker Glutathione Peroxidase: A Randomised Trial of Patients with Cancer and Benign Disease.
Topics: Aged; Analgesia; Anesthetics, Local; Biomarkers; Bupivacaine; Disease; Female; Glutathione Peroxidas | 2017 |
Does Rectus Sheath Block Analgesia Alter Levels of the Oxidative Stress Biomarker Glutathione Peroxidase: A Randomised Trial of Patients with Cancer and Benign Disease.
Topics: Aged; Analgesia; Anesthetics, Local; Biomarkers; Bupivacaine; Disease; Female; Glutathione Peroxidas | 2017 |
Complications of intrathecal opioids and bupivacaine in the treatment of "refractory" cancer pain.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bupivacaine; Catheterization; Cohort Studies; Equipment | 1995 |
Complications of intrathecal opioids and bupivacaine in the treatment of "refractory" cancer pain.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bupivacaine; Catheterization; Cohort Studies; Equipment | 1995 |
Postoperative pulmonary complications. Epidural analgesia using bupivacaine and opioids versus parenteral opioids.
Topics: Abdomen; Adult; Aged; Analgesia, Epidural; Anesthesia, Epidural; Anesthesia, General; Bupivacaine; D | 1993 |
Postoperative pulmonary complications. Epidural analgesia using bupivacaine and opioids versus parenteral opioids.
Topics: Abdomen; Adult; Aged; Analgesia, Epidural; Anesthesia, Epidural; Anesthesia, General; Bupivacaine; D | 1993 |
Prolongation of epidural bupivacaine analgesia with glycerin.
Topics: Aged; Analgesia, Epidural; Bupivacaine; Chronic Disease; Delayed-Action Preparations; Female; Glycer | 1993 |
Prolongation of epidural bupivacaine analgesia with glycerin.
Topics: Aged; Analgesia, Epidural; Bupivacaine; Chronic Disease; Delayed-Action Preparations; Female; Glycer | 1993 |
Intrathecal coadministration of bupivacaine diminishes morphine dose progression during long-term intrathecal infusion in cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Anesthetics, Local; Bupivacaine; Dose-Response R | 1999 |
Intrathecal coadministration of bupivacaine diminishes morphine dose progression during long-term intrathecal infusion in cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Anesthetics, Local; Bupivacaine; Dose-Response R | 1999 |
40 other studies available for bupivacaine and Neoplasms
Article | Year |
---|---|
First Evaluation Switching From Ropivacaine to Highly Concentrated Bupivacaine in Intrathecal Mixtures for Cancer Pain.
Topics: Amides; Anesthetics, Local; Bupivacaine; Cancer Pain; Double-Blind Method; Humans; Neoplasms; Retros | 2021 |
First Evaluation Switching From Ropivacaine to Highly Concentrated Bupivacaine in Intrathecal Mixtures for Cancer Pain.
Topics: Amides; Anesthetics, Local; Bupivacaine; Cancer Pain; Double-Blind Method; Humans; Neoplasms; Retros | 2021 |
Factors Associated with Inadequate Pain Control among Postoperative Patients with Cancer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analgesia, Epidural; Bupivacaine; Cross-Sectional Studie | 2018 |
Factors Associated with Inadequate Pain Control among Postoperative Patients with Cancer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analgesia, Epidural; Bupivacaine; Cross-Sectional Studie | 2018 |
Audit of intrathecal drug delivery for patients with difficult-to-control cancer pain shows a sustained reduction in pain severity scores over a 6-month period.
Topics: Adult; Aged; Analgesics, Opioid; Bupivacaine; Female; Humans; Infusion Pumps, Implantable; Injection | 2015 |
Audit of intrathecal drug delivery for patients with difficult-to-control cancer pain shows a sustained reduction in pain severity scores over a 6-month period.
Topics: Adult; Aged; Analgesics, Opioid; Bupivacaine; Female; Humans; Infusion Pumps, Implantable; Injection | 2015 |
A case of cancer pain management by long-term intrathecal PCA.
Topics: Adult; Analgesia, Patient-Controlled; Bupivacaine; Female; Humans; Injections, Spinal; Ketamine; Mor | 2010 |
A case of cancer pain management by long-term intrathecal PCA.
Topics: Adult; Analgesia, Patient-Controlled; Bupivacaine; Female; Humans; Injections, Spinal; Ketamine; Mor | 2010 |
Efficacy of epidural analgesia in patients with cancer pain: a retrospective observational study.
Topics: Adult; Analgesia, Epidural; Bupivacaine; Female; Humans; Male; Middle Aged; Morphine; Neoplasms; Pai | 2012 |
Efficacy of epidural analgesia in patients with cancer pain: a retrospective observational study.
Topics: Adult; Analgesia, Epidural; Bupivacaine; Female; Humans; Male; Middle Aged; Morphine; Neoplasms; Pai | 2012 |
Opioid "holiday" following antagonist supported detoxification during general anesthesia improves opioid agonist response in a cancer patient with opioid addiction.
Topics: Analgesia, Epidural; Analgesics, Opioid; Anesthesia, General; Anesthetics, Local; Bone Neoplasms; Bu | 2003 |
Opioid "holiday" following antagonist supported detoxification during general anesthesia improves opioid agonist response in a cancer patient with opioid addiction.
Topics: Analgesia, Epidural; Analgesics, Opioid; Anesthesia, General; Anesthetics, Local; Bone Neoplasms; Bu | 2003 |
Local anesthetic switching for intrathecal tachyphylaxis in cancer patients with pain.
Topics: Adult; Anesthetics, Local; Bupivacaine; Carcinoma, Small Cell; Endometrial Neoplasms; Female; Humans | 2003 |
Local anesthetic switching for intrathecal tachyphylaxis in cancer patients with pain.
Topics: Adult; Anesthetics, Local; Bupivacaine; Carcinoma, Small Cell; Endometrial Neoplasms; Female; Humans | 2003 |
Local anesthetic switching for intrathecal tachyphylaxis in cancer patients with pain.
Topics: Analgesics, Opioid; Anesthetics, Dissociative; Anesthetics, Local; Bupivacaine; Humans; Injections, | 2004 |
Local anesthetic switching for intrathecal tachyphylaxis in cancer patients with pain.
Topics: Analgesics, Opioid; Anesthetics, Dissociative; Anesthetics, Local; Bupivacaine; Humans; Injections, | 2004 |
Efficacy of intrathecal bupivacaine: how important is the flow rate?
Topics: Aged; Anesthetics, Local; Bupivacaine; Dose-Response Relationship, Drug; Female; Humans; Infusion Pu | 2004 |
Efficacy of intrathecal bupivacaine: how important is the flow rate?
Topics: Aged; Anesthetics, Local; Bupivacaine; Dose-Response Relationship, Drug; Female; Humans; Infusion Pu | 2004 |
Evolving spinal analgesia practice in palliative care.
Topics: Adult; Aged; Aged, 80 and over; Analgesia; Analgesia, Epidural; Analgesics, Opioid; Anesthetics, Loc | 2004 |
Evolving spinal analgesia practice in palliative care.
Topics: Adult; Aged; Aged, 80 and over; Analgesia; Analgesia, Epidural; Analgesics, Opioid; Anesthetics, Loc | 2004 |
Alternative treatments of breakthrough pain in patients receiving spinal analgesics for cancer pain.
Topics: Administration, Sublingual; Adult; Aged; Analgesics; Anesthetics, Local; Bupivacaine; Female; Humans | 2005 |
Alternative treatments of breakthrough pain in patients receiving spinal analgesics for cancer pain.
Topics: Administration, Sublingual; Adult; Aged; Analgesics; Anesthetics, Local; Bupivacaine; Female; Humans | 2005 |
[Possibilities and limitations of morphine analgesia in 377 cases].
Topics: Anesthesia, Epidural; Anesthesia, Spinal; Back Pain; Bupivacaine; Dexamethasone; Humans; Injections, | 1983 |
[Possibilities and limitations of morphine analgesia in 377 cases].
Topics: Anesthesia, Epidural; Anesthesia, Spinal; Back Pain; Bupivacaine; Dexamethasone; Humans; Injections, | 1983 |
Intrathecal morphine and bupivacaine in advanced cancer pain patients implanted at home.
Topics: Aged; Bupivacaine; Catheterization; Home Care Services; Humans; Injections, Spinal; Male; Middle Age | 1994 |
Intrathecal morphine and bupivacaine in advanced cancer pain patients implanted at home.
Topics: Aged; Bupivacaine; Catheterization; Home Care Services; Humans; Injections, Spinal; Male; Middle Age | 1994 |
Postoperative epidural bupivacaine-morphine therapy. Experience with 4,227 surgical cancer patients.
Topics: Adult; Aged; Analgesia, Epidural; Bupivacaine; Catheters, Indwelling; Drug Combinations; Female; Hum | 1994 |
Postoperative epidural bupivacaine-morphine therapy. Experience with 4,227 surgical cancer patients.
Topics: Adult; Aged; Analgesia, Epidural; Bupivacaine; Catheters, Indwelling; Drug Combinations; Female; Hum | 1994 |
Long-term intrathecal infusion of morphine and morphine/bupivacaine mixtures in the treatment of cancer pain: a retrospective analysis of 51 cases.
Topics: Adult; Aged; Bupivacaine; Catheterization; Drug Combinations; Female; Humans; Injections, Spinal; Ma | 1993 |
Long-term intrathecal infusion of morphine and morphine/bupivacaine mixtures in the treatment of cancer pain: a retrospective analysis of 51 cases.
Topics: Adult; Aged; Bupivacaine; Catheterization; Drug Combinations; Female; Humans; Injections, Spinal; Ma | 1993 |
Long-term intrathecal morphine and bupivacaine in patients with refractory cancer pain. Results from a morphine:bupivacaine dose regimen of 0.5:4.75 mg/ml.
Topics: Adult; Aged; Aged, 80 and over; Bupivacaine; Female; Humans; Injections, Spinal; Male; Middle Aged; | 1994 |
Long-term intrathecal morphine and bupivacaine in patients with refractory cancer pain. Results from a morphine:bupivacaine dose regimen of 0.5:4.75 mg/ml.
Topics: Adult; Aged; Aged, 80 and over; Bupivacaine; Female; Humans; Injections, Spinal; Male; Middle Aged; | 1994 |
Epidural bupivacaine/sufentanil therapy for postoperative pain control in patients tolerant to opioid and unresponsive to epidural bupivacaine/morphine.
Topics: Abdomen; Adult; Analgesia, Epidural; Bupivacaine; Chronic Disease; Drug Tolerance; Female; Humans; M | 1994 |
Epidural bupivacaine/sufentanil therapy for postoperative pain control in patients tolerant to opioid and unresponsive to epidural bupivacaine/morphine.
Topics: Abdomen; Adult; Analgesia, Epidural; Bupivacaine; Chronic Disease; Drug Tolerance; Female; Humans; M | 1994 |
CSF neuropeptides in cancer pain: effects of spinal opioid therapy.
Topics: Aged; Bupivacaine; Female; Humans; Injections, Epidural; Injections, Spinal; Male; Methadone; Middle | 1993 |
CSF neuropeptides in cancer pain: effects of spinal opioid therapy.
Topics: Aged; Bupivacaine; Female; Humans; Injections, Epidural; Injections, Spinal; Male; Methadone; Middle | 1993 |
A comparison of postoperative epidural analgesia between patients with chronic cancer taking high doses of oral opioids versus opioid-naive patients.
Topics: Administration, Oral; Adult; Aged; Analgesia, Epidural; Bupivacaine; Chronic Disease; Female; Humans | 1993 |
A comparison of postoperative epidural analgesia between patients with chronic cancer taking high doses of oral opioids versus opioid-naive patients.
Topics: Administration, Oral; Adult; Aged; Analgesia, Epidural; Bupivacaine; Chronic Disease; Female; Humans | 1993 |
[Treatment of severe cancer pain via spinal catheters].
Topics: Adult; Aged; Analgesics, Opioid; Anesthetics, Local; Bupivacaine; Female; Humans; Infusion Pumps, Im | 1996 |
[Treatment of severe cancer pain via spinal catheters].
Topics: Adult; Aged; Analgesics, Opioid; Anesthetics, Local; Bupivacaine; Female; Humans; Infusion Pumps, Im | 1996 |
Neurological impairment during long-term intrathecal infusion of bupivacaine in cancer patients: a sign of spinal cord compression.
Topics: Aged; Analgesics, Opioid; Anesthetics, Local; Bupivacaine; Drug Combinations; Female; Humans; Inject | 1997 |
Neurological impairment during long-term intrathecal infusion of bupivacaine in cancer patients: a sign of spinal cord compression.
Topics: Aged; Analgesics, Opioid; Anesthetics, Local; Bupivacaine; Drug Combinations; Female; Humans; Inject | 1997 |
Neurohistopathological findings after continuous intrathecal administration of morphine or a morphine/bupivacaine mixture in cancer pain patients.
Topics: Adult; Aged; Analgesics, Opioid; Anesthetics, Local; Bupivacaine; Dura Mater; Female; Humans; Infusi | 1997 |
Neurohistopathological findings after continuous intrathecal administration of morphine or a morphine/bupivacaine mixture in cancer pain patients.
Topics: Adult; Aged; Analgesics, Opioid; Anesthetics, Local; Bupivacaine; Dura Mater; Female; Humans; Infusi | 1997 |
Neurolytic thoracic paravertebral block in cancer pain. A clinical report.
Topics: Acute Disease; Adult; Aged; Analgesics; Anesthetics, Local; Bupivacaine; Chronic Disease; Female; Fo | 1998 |
Neurolytic thoracic paravertebral block in cancer pain. A clinical report.
Topics: Acute Disease; Adult; Aged; Analgesics; Anesthetics, Local; Bupivacaine; Chronic Disease; Female; Fo | 1998 |
The use of interpleural analgesia using bupivacaine for pain relief in advanced cancer.
Topics: Adult; Aged; Analgesia; Anesthetics, Local; Bupivacaine; Catheterization; Female; Home Nursing; Huma | 1999 |
The use of interpleural analgesia using bupivacaine for pain relief in advanced cancer.
Topics: Adult; Aged; Analgesia; Anesthetics, Local; Bupivacaine; Catheterization; Female; Home Nursing; Huma | 1999 |
Chronic epidural bupivacaine-opioid infusion in intractable cancer pain.
Topics: Analgesia, Epidural; Blood Pressure; Bupivacaine; Drug Therapy, Combination; Humans; Narcotics; Neop | 1992 |
Chronic epidural bupivacaine-opioid infusion in intractable cancer pain.
Topics: Analgesia, Epidural; Blood Pressure; Bupivacaine; Drug Therapy, Combination; Humans; Narcotics; Neop | 1992 |
[Intrathecal morphine therapy in children with cancer].
Topics: Bupivacaine; Child; Child, Preschool; Female; Fentanyl; Humans; Infant; Injections, Spinal; Male; Mo | 1992 |
[Intrathecal morphine therapy in children with cancer].
Topics: Bupivacaine; Child; Child, Preschool; Female; Fentanyl; Humans; Infant; Injections, Spinal; Male; Mo | 1992 |
Comments on PAIN, 49 (1992) 293-300.
Topics: Analgesia, Epidural; Bupivacaine; Humans; Neoplasms; Pain | 1992 |
Comments on PAIN, 49 (1992) 293-300.
Topics: Analgesia, Epidural; Bupivacaine; Humans; Neoplasms; Pain | 1992 |
Management of patients receiving combined epidural morphine and bupivacaine for the treatment of cancer pain.
Topics: Adult; Analgesia, Epidural; Bupivacaine; Drug Therapy, Combination; Female; Humans; Morphine; Neopla | 1992 |
Management of patients receiving combined epidural morphine and bupivacaine for the treatment of cancer pain.
Topics: Adult; Analgesia, Epidural; Bupivacaine; Drug Therapy, Combination; Female; Humans; Morphine; Neopla | 1992 |
[Epidural administration of bupivacaine in glycerine solution can prolong analgesia].
Topics: Adult; Analgesia, Epidural; Bupivacaine; Female; Glycerol; Humans; Injections, Epidural; Male; Middl | 1992 |
[Epidural administration of bupivacaine in glycerine solution can prolong analgesia].
Topics: Adult; Analgesia, Epidural; Bupivacaine; Female; Glycerol; Humans; Injections, Epidural; Male; Middl | 1992 |
Neuropathologic findings after long-term intrathecal infusion of morphine and bupivacaine for pain treatment in cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Bupivacaine; Female; Humans; Injections, Spinal; Male; Meninges; Mid | 1992 |
Neuropathologic findings after long-term intrathecal infusion of morphine and bupivacaine for pain treatment in cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Bupivacaine; Female; Humans; Injections, Spinal; Male; Meninges; Mid | 1992 |
Epidural opiates and local anesthetics for the management of cancer pain.
Topics: Adult; Aged; Analgesia, Epidural; Bupivacaine; Drug Therapy, Combination; Female; Humans; Male; Midd | 1991 |
Epidural opiates and local anesthetics for the management of cancer pain.
Topics: Adult; Aged; Analgesia, Epidural; Bupivacaine; Drug Therapy, Combination; Female; Humans; Male; Midd | 1991 |
Long-term, open catheterization of the spinal subarachnoid space for continuous infusion of narcotic and bupivacaine in patients with "refractory" cancer pain. A technique of catheterization and its problems and complications.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anesthesia; Anesthesia, Local; Anti-Bacterial Agents; Bu | 1991 |
Long-term, open catheterization of the spinal subarachnoid space for continuous infusion of narcotic and bupivacaine in patients with "refractory" cancer pain. A technique of catheterization and its problems and complications.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anesthesia; Anesthesia, Local; Anti-Bacterial Agents; Bu | 1991 |
Long-term intrathecal morphine and bupivacaine in "refractory" cancer pain. I. Results from the first series of 52 patients.
Topics: Adult; Aged; Aged, 80 and over; Bupivacaine; Female; Humans; Injections, Spinal; Male; Middle Aged; | 1991 |
Long-term intrathecal morphine and bupivacaine in "refractory" cancer pain. I. Results from the first series of 52 patients.
Topics: Adult; Aged; Aged, 80 and over; Bupivacaine; Female; Humans; Injections, Spinal; Male; Middle Aged; | 1991 |
Epidural versus intrathecal morphine-bupivacaine: assessment of consecutive treatments in advanced cancer pain.
Topics: Adult; Aged; Aged, 80 and over; Analgesia, Epidural; Bupivacaine; Dose-Response Relationship, Drug; | 1990 |
Epidural versus intrathecal morphine-bupivacaine: assessment of consecutive treatments in advanced cancer pain.
Topics: Adult; Aged; Aged, 80 and over; Analgesia, Epidural; Bupivacaine; Dose-Response Relationship, Drug; | 1990 |
Spinal bupivacaine for the pain of cancer.
Topics: Adult; Aged; Anesthesia, Spinal; Bupivacaine; Humans; Middle Aged; Neoplasms; Pain, Intractable; Pal | 1989 |
Spinal bupivacaine for the pain of cancer.
Topics: Adult; Aged; Anesthesia, Spinal; Bupivacaine; Humans; Middle Aged; Neoplasms; Pain, Intractable; Pal | 1989 |
Lumbar epidurography and epidural analgesia in cancer patients.
Topics: Adult; Analgesia, Epidural; Bupivacaine; Epidural Space; Female; Humans; Iohexol; Lumbosacral Region | 1989 |
Lumbar epidurography and epidural analgesia in cancer patients.
Topics: Adult; Analgesia, Epidural; Bupivacaine; Epidural Space; Female; Humans; Iohexol; Lumbosacral Region | 1989 |
Spinal relief of cancer pain.
Topics: Anesthesia, Epidural; Anesthesia, Spinal; Bupivacaine; Catheterization; Drug Tolerance; Humans; Inje | 1986 |
Spinal relief of cancer pain.
Topics: Anesthesia, Epidural; Anesthesia, Spinal; Bupivacaine; Catheterization; Drug Tolerance; Humans; Inje | 1986 |
[Hygienic relations and stability of drugs in peridural long-term infusion with implanted or external pumps].
Topics: Abscess; Anesthesia, Epidural; Bacterial Infections; Bacteriological Techniques; Bupivacaine; Drug C | 1985 |
[Hygienic relations and stability of drugs in peridural long-term infusion with implanted or external pumps].
Topics: Abscess; Anesthesia, Epidural; Bacterial Infections; Bacteriological Techniques; Bupivacaine; Drug C | 1985 |
Treatment of intractable pain by bupivacaine nerve-block.
Topics: Aged; Analgesia; Anesthesia, Conduction; Anesthetics, Local; Bupivacaine; Female; Humans; Male; Midd | 1971 |
Treatment of intractable pain by bupivacaine nerve-block.
Topics: Aged; Analgesia; Anesthesia, Conduction; Anesthetics, Local; Bupivacaine; Female; Humans; Male; Midd | 1971 |
Relieving pain in the terminally ill.
Topics: Administration, Oral; Alcohols; Anesthesia, Spinal; Antidepressive Agents; Autonomic Nerve Block; Bu | 1973 |
Relieving pain in the terminally ill.
Topics: Administration, Oral; Alcohols; Anesthesia, Spinal; Antidepressive Agents; Autonomic Nerve Block; Bu | 1973 |